A coenzyme involved in cellular metabolism, examined in a small human metabolite-tracking study.
In simple words
NAD+ is nicotinamide adenine dinucleotide, a coenzyme that helps cells carry out metabolic reactions. NAD+ is not a peptide; the selected small human study tracked metabolites rather than demonstrating reversal of ageing.
NAD+ is a coenzyme, not a peptide. Studies of NR or NMN are not automatically evidence for NAD+ itself.
Researchers measured plasma and urinary metabolites during and after an NAD+ infusion, documenting how the administered compound was processed.
This small, short metabolic study did not test longevity, cognitive improvement or disease prevention and cannot establish long-term safety. NAD+ is not interchangeable with its precursors NR or NMN.
PMID 31572171. Open full text checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Resources
Identity search; no unambiguous compound record assigned to this listing. Check forms and synonyms carefully.
Evidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about NAD+
What is NAD+?
NAD+ is nicotinamide adenine dinucleotide, a coenzyme that helps cells carry out metabolic reactions. NAD+ is not a peptide; the selected small human study tracked metabolites rather than demonstrating reversal of ageing.
What types of research are cited for NAD+?
The NAD+ profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.
NAD+ metabolism: pilot study (2019): Human — small metabolic pilot
NAD+ is a coenzyme, not a peptide. Studies of NR or NMN are not automatically evidence for NAD+ itself.
What do the selected NAD+ studies not establish?
NAD+ metabolism: pilot study (2019): This small, short metabolic study did not test longevity, cognitive improvement or disease prevention and cannot establish long-term safety. NAD+ is not interchangeable with its precursors NR or NMN.
These studies do not establish the identity, purity, safety or effects of the MXC NAD+ vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.